TITLE

SEVERE CHRONIC URTICARIA TREATED WITH ORAL MINI-PULSE STEROID THERAPY

AUTHOR(S)
Godse, Kiran V.
PUB. DATE
October 2010
SOURCE
Indian Journal of Dermatology;Oct-Dec2010, Vol. 55 Issue 4, p402
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The article presents a study on the effectiveness of oral mini-pulse (OMP) for treating severe chronic urticaria. For the study, researchers examined 10 patients treated with OMP along with methylprednisolone and oral levocetirizine. One patient experienced weight gain and epigastric pain. Another patient experienced worsened symptoms following the termination of steroids.
ACCESSION #
57270742

 

Related Articles

  • Nexavar®-related adverse reactions: Calabrian (Italy) experience for sorafenib exposition in 2012. Cilurzo, Felisa; Staltari, Orietta; PatanèMichele Ammendola, Marinella; Ammendola, Michele; Garaffo, Caterina; Paola, Eugenio Donato Di // Journal of Pharmacology & Pharmacotherapeutics;Dec2013 Supplement 1, Vol. 4 Issue 5, p86 

    Hepatocellular carcinoma (HCC) remains a major global health problem and Calabria in the south of Italy is not an exception. Sorafenib is the first and only Food and Drug Administration approved drug for the treatment of advanced HCC and it is currently under intensive monitoring by the Health...

  • A randomized placebo-controlled double-blind pilot study of methotrexate in the treatment of H1 antihistamine-resistant chronic spontaneous urticaria. Sharma, Vinod K.; Singh, Saurabh; Ramam, M.; Kumawat, Mahesh; Kumar, Rakesh // Indian Journal of Dermatology, Venereology & Leprology;Mar/Apr2014, Vol. 80 Issue 2, p122 

    Background: Chronic urticaria not responsive to antihistamines is a difficult disease to manage. Methotrexate has been used in difficult chronic urticarias with some benefit. Objective: To evaluate the efficacy of methotrexate in the treatment of chronic spontaneous urticaria poorly responsive...

  • TNF-Alpha Inhibitors for Chronic Urticaria: Experience in 20 Patients. Sand, Freja Lærke; Thomsen, Simon Francis // Journal of Allergy;2013, p1 

    Patients with severe chronic urticaria may not respond to antihistamines, and other systemic treatment options may either be ineffective or associated with unacceptable side effects. We present data on efficacy and safety of adalimumab and etanercept in 20 adult patients with chronic urticaria....

  • Weekly azathioprine pulse versus daily azathioprine in the treatment of Parthenium dermatitis: A non-inferiority randomized controlled study. Verma, Kaushal K.; Sethuraman, G.; Kalavani, M. // Indian Journal of Dermatology, Venereology & Leprology;May/Jun2015, Vol. 81 Issue 3, p251 

    Background: Azathioprine in daily doses has been shown to be effective and safe in the treatment of Parthenium dermatitis. Weekly pulses of azathioprine (WAP) are also effective, but there are no reports comparing the effectiveness and safety of these two regimens in this condition. Aims: To...

  • Fluocinonide Topical.  // AHFS Consumer Medication Information;Apr2018, p1 

    Fluocinonide is used to treat the itching, redness, dryness, crusting, scaling, inflammation, and discomfort of various skin conditions. This medication is sometimes prescribed for other uses; ask your doctor or pharmacist for more information.

  • Flurandrenolide Topical.  // AHFS Consumer Medication Information;Apr2018, p1 

    Flurandrenolide is used to treat the itching, redness, dryness, crusting, scaling, inflammation, and discomfort of various skin conditions. This medication is sometimes prescribed for other uses; ask your doctor or pharmacist for more information.

  • Imiquimod.  // Reactions Weekly;2/6/2010, Issue 1287, p25 

    The article describes the case of an older man who developed erosive pustular dermatosis after receiving imiquimod.

  • Influenza A virus vaccine-H1N1.  // Reactions Weekly;2/12/2011, Issue 1338, p23 

    The article describes the case of a 55-year-old woman who developed allergic contact dermatitis after receiving the influenza A virus vaccine H1N1, which contained thiomersal as an excipient.

  • Erlotinib.  // Reactions Weekly;2/13/2010, Issue 1288, p17 

    The article describes the case of a 77-year-old woman who developed radiation recall dermatitis after starting erlotinib for metastatic colon cancer.

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics